Reed Smith is pleased to present a Life Sciences Litigation CLE Day designed for in-house counsel at pharmaceutical, medical device, and biotech companies.

Sessions – detailed below – will cover hot topics and key developments in product liability, digital health and e-discovery.

Speakers: David R. Cohen Mildred Segura James M. Beck Jennifer A. Eppensteiner Cori Annapolen Goldberg Sung W. Park Joseph J. Mahady Heather A. Ritch Rocks Sarah B. Johansen Stephen J. McConnell Shana E. Russo Alexandra E. Hussey Elizabeth C. Brandon Janet H. Kwuon Melissa A. Geist

Event Type: Webinar

Start Date/Time:
16 November 2023, 10:00 AM ET
End Date/Time:
16 November 2023, 4:30 PM ET

Important CLE information: This event is presumptively approved for 4.25 general and 1.0 ethics credit in California, Connecticut, Illinois, Texas and West Virginia, 5.1 general and 1.2 ethics credit in New Jersey, 5.0 general and 1.0 ethics in New York and 4.0 general and 1.0 ethics in Pennsylvania. Applications for CLE credit will be filed in Delaware, Florida, Ohio, and Virginia.

You be the judge: ethics edition

Join us for a fun, interactive game that will test your knowledge of legal ethics rules surrounding e-discovery. We will present relevant facts from several recent cases. For each case, you will be presented with key e-discovery ethical questions faced by the judge. Your role is to decide how the judge ruled – or should have ruled!


  • David Cohen, Partner, Pittsburgh
  • Mildred Segura, Partner, Los Angeles

Challenges in digital health and AI: current regulatory and product liability landscape and preparing for what’s ahead

Companies operating in the digital health, artificial intelligence and machine learning space have quickly appreciated that the sophistication and technology involved in their products is light years ahead of the laws and regulations intended to govern them. This disparity is evident in how these products are regulated by the FDA, how these companies commercialize their products and offerings, and how their products can be used in the provision of health care services. Our panel discussion will provide an overview of the current regulatory framework in place, including recent updates from FDA, as well as the current product liability legal landscape, including what we think is ahead for this segment of the industry, which is expected to experience continued explosive growth in the next decade.


  • Cori Annapolen Goldberg, Partner, New York 
  • Mildred Segura, Partner, Los Angeles
  • Sung Park, Counsel, Washington, D.C.